Stockscreener 앱 받기
8.94
3.83%
0.33
Electra Therapeutics, Inc. Common stock 주식(ETRA)의 최신 뉴스
Two entities report shared voting power over more than 5% of Electra Therapeutics (ETRA). - Stock Titan
An investment manager reports a stake above 5% in Electra Therapeutics (ETRA) after its IPO. - Stock Titan
OrbiMed Advisors Discloses Investment at Electra Therapeutics with 11.0% Stake - TradingView
Two funds bought Electra Therapeutics (ETRA) IPO shares at $15. OrbiMed reports their stake. - Stock Titan
Total common shares outstanding of Electra Therapeutics, Inc. – NASDAQ:ETRA - TradingView
Form 4 Electra Therapeutics For: 23 September By Investing.com - Investing.com Nigeria
ETRA SEC Filings, Sep 18, 2026Electra Therapeutics, Inc. Filing Archive - stocktitan.net
Form 4 Electra Therapeutics For: 23 September By Investing.com - Investing.com South Africa
A $15 IPO brought share purchases and preferred-stock conversions at Electra Therapeutics (ETRA). - Stock Titan
At $15 a share, OrbiMed funds bought Electra Therapeutics (ETRA) stock as preferred shares converted. - Stock Titan
Total common shares outstanding of Electra Therapeutics, Inc. – BOATS:ETRA - TradingView
Electra Therapeutics, Inc. Statistics – NASDAQ:ETRA - TradingView
OrbiMed Discloses Preferred Stock Conversion and Significant IPO Share Acquisitions in Electra Therapeutics - Kalkine Media
[Form 4] Electra Therapeutics, Inc. Insider Trading Activity - Stock Titan
Electra Therapeutics (ETRA) director converts 255K preferred in IPO - Stock Titan
Electra Therapeutics (ETRA) CEO converts preferred stake into 455,484 common shares tied to IPO - Stock Titan
Electra Therapeutics (ETRA) Stock Price, News & Analysis - Stock Titan
[Form 4] Electra Therapeutics, Inc. Insider Trading Activity - stocktitan.net
Electra Therapeutics, Inc. Common stock (ETRA) stock price, news, quote and history - Yahoo Finance Australia
Kinzey Capital Management: Electra Sets Nasdaq IPO Terms - GlobeNewswire Inc.
ETRA SEC Filings, Sep 18, 2026Electra Therapeutics, Inc. Filing Archive - Stock Titan
Electra Therapeutics (ETRA) CFO reveals 612K options running to 2036 - Stock Titan
Electra Therapeutics (ETRA) details 2036 option grants for accounting chief - Stock Titan
Electra Therapeutics (ETRA) director details three long-term option grants - Stock Titan
Parry Graham discloses two stock option holdings at Electra Therapeutics (ETRA) - Stock Titan
[Form 3] Electra Therapeutics, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Electra CEO’s option and preferred stake (ETRA) - Stock Titan
Electra Therapeutics (ETRA) CSO discloses stock options and IPO-convertible preferred shares - Stock Titan
OrbiMed funds’ Electra Therapeutics (ETRA) preferred holdings and a director option detailed - Stock Titan
ETRA SEC FilingsElectra Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Electra Therapeutics (ETRA) pursues IPO as auditor raises going-concern warning - Stock Titan
Latham & Watkins Advises on Electra Therapeutics’ Upsized US$350 Million Initial Public Offering - Latham & Watkins LLP
Electra Therapeutics, Inc. Common stock (ETRA) stock price, news, quote and history - Yahoo Finance UK
Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering - GlobeNewswire
Dear Future Electra Therapeutics Stock Fans, Mark Your Calendars for Sept. 18 - Yahoo Finance
Electra amasses $350M in biotech’s latest big IPO - BioPharma Dive
Electra Therapeutics Files for US IPO - Yahoo Finance
Electra Therapeutics files for IPO to fund immune disease drugs By Investing.com - Investing.com India
Electra Therapeutics files for IPO to fund immune disease drugs - Investing.com
6.10%
5.71%
자본화:
|
볼륨(24시간):